Consensus InspireMD, Inc.

Equities

NSPR

US45779A8466

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
2 ^USD	+4.44%		-4.31%	-28.83%

Mar. 06	Transcript : InspireMD, Inc., Q4 2023 Earnings Call, Mar 06, 2024
Mar. 06	Earnings Flash (NSPR) INSPIREMD Posts Q4 Revenue $1.8M	MT

Evolution of the average Target Price on InspireMD, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e2ca7edc9fba7dee0c353b2e6ddfb.nAENY7m9KJbV9megT0cc7hpofJOZizctELs02uFrhHc.z1B-Aorsf6L4vh7MJxgoj3ddMfTKyX5dctlAsq88txXSY2AP4PNQ5Oy9Ig~02fc8ada9796c9de937375b989f863d3

Analyst Recommendations on InspireMD, Inc.

Piper Sandler Initiates InspireMD at Overweight With $3 Price Target	23-06-12	MT
Alliance Global Adjusts Price Target on InspireMD to $4.75 From $5.15, Maintains Buy Rating	23-05-17	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2 USD

Average target price

4.5 USD

Spread / Average Target

+125.00%

High Price Target

4.5 USD

Spread / Highest target

+125.00%

Low Price Target

4.5 USD

Spread / Lowest Target

+125.00%

Consensus detail

Consensus revision (last 18 months)

Analysts covering InspireMD, Inc.

Piper Sandler
Alliance Global Partners

Quarterly earnings - Rate of surprise

Company calendar